Showing results (531-540 of 1,136) with videos related to
Sort By:
Pageof 114
Journal of Hepatocellular Carcinoma|October 5, 2026
Hispidulin Suppresses Hepatocellular Carcinoma Proliferation by Targeting PI3K-Akt Pathway: A Network Pharmacology and Experimental Validation StudyXulei Zhang, Yuan Yang, Zhiyuan Xu, et al.Journal of Hepatocellular Carcinoma|October 7, 2026
Very Early Recurrence as a Dynamic Prognostic Stratifier After Curative Hepatectomy for Hepatocellular Carcinoma: A Landmark Analysis with Internal Validation and Machine-Learning BenchmarkingYun Cong, Ziwei Ma, Shitao Lei, et al.Journal of Hepatocellular Carcinoma|October 13, 2026
Surgical Management of Hepatocellular Carcinoma Complicated by Severe Portal Hypertension Secondary to an Arterioportal Shunt: A Case ReportHiroshi Shintani, Satoshi Wakama, Shota Ueda, et al.Journal of Hepatocellular Carcinoma|October 15, 2026
Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCCFeixiang Xiong, Xuejie Zhang, Dandan Chen, et al.Journal of Hepatocellular Carcinoma|October 17, 2026
Dysregulation of miRNA-2116-3p Predicts Prognosis of Hepatocellular Carcinoma and Regulates Tumor Cell Proliferation and MigrationQitian Sun, Changrong Ren, Ziyu Bai, et al.Journal of Hepatocellular Carcinoma|November 10, 2021
Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching StudyHui-Zhou Li, Jie Tan, Tian Tang, et al.Journal of Hepatocellular Carcinoma|December 1, 2021
Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCCDavide De Battista, Fausto Zamboni, Hannah Gerstein, et al.Journal of Hepatocellular Carcinoma|February 22, 2019
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidanceKhaled M Elsayes, Ania Z Kielar, Victoria Chernyak, et al.Journal of Hepatocellular Carcinoma|December 8, 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Lorenz Balcar, Bernhard Scheiner, et al.Journal of Hepatocellular Carcinoma|December 9, 2021
PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune InfiltrationXin Liu, Yize Zhang, Zenghan Wang, et al.Pageof 114